LAURA OLIPHANT - Corporate Board Profile

AEHR TEST SYSTEMS

Filing Date	Source Excerpt
2019-09-26	The Audit Committee currently consists of directors Oliphant, Schneider and Slayen, each of whom is an independent member of the Board of Directors, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect. The Compensation Committee of the Board of Directors currently consists of directors Oliphant and Slayen, each of whom is an independent member of the Board of Directors, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect.
2020-09-24	Laura Oliphant has been a director of the Company since July 2019. From 2016 to 2018, she was the Chief Executive Officer of Translarity, a venture funded probe card company. From 2001 to 2016, she served as an Investment Director at Intel Capital, Intel’s venture capital organization, where she made and managed investments in the semiconductor capital equipment and materials area and received Intel’s highest award for the strategic impact of her contributions. She is a holder of the National Association of Corporate Directors Board Leadership Fellowship. Dr. Oliphant received a BE in Chemical Engineering from Manhattan College in Riverdale, New York, and PhD in Chemical Engineering from the University of California, Berkeley. The Audit Committee currently consists of directors Oliphant, Scott and Slayen, each of whom is an independent member of the Board, as defined by the NASDAQ Capital Market (“Nasdaq”), director independence standards, as well as applicable SEC rules, as currently in effect. The Compensation Committee of the Board currently consists of directors Oliphant and Slayen, each of whom is an independent member of the Board, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect. The Compensation Committee Chair is Laura Oliphant. The Corporate Governance and Nominating Committee of the Board currently consists of directors Oliphant, Rosati and Scott, each of whom is an independent member of the Board, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect.
2021-09-24	Laura Oliphant has been a director of the Company since July 2019. The Audit Committee currently consists of directors Oliphant, Scott and Slayen. The Audit Committee Chair is Howard Slayen. The Compensation Committee of the Board currently consists of directors Danesh, Oliphant and Slayen. The Compensation Committee Chair is Laura Oliphant. The Corporate Governance and Nominating Committee of the Board currently consists of directors Oliphant, Rosati and Scott. The Corporate Governance and Nominating Committee Chair is Mario Rosati. The following table sets forth the compensation paid by the Company during the fiscal year ended May 31, 2021 to the Company’s directors other than Mr. Erickson: Laura Oliphant 2021 Total $67,487.
2022-09-23	Laura Oliphant has been a director of the Company since July 2019. From 2016 to 2018, she was the Chief Executive Officer of Translarity, a venture funded probe card company. From 2001 to 2016, she served as an Investment Director at Intel Capital, Intel’s venture capital organization, where she made and managed investments in the semiconductor capital equipment and materials area and received Intel’s highest award for the strategic impact of her contributions. Dr. Oliphant is a National Association of Corporate Directors (NACD) Board Leadership Fellow and was named to the 2022 NACD Directorship 100 for her strategic impact in the boardroom. She received a BE in Chemical Engineering from Manhattan College in Riverdale, New York, and PhD in Chemical Engineering from the University of California, Berkeley. The Audit Committee currently consists of directors Oliphant, Scott and Slayen, each of whom is an independent member of the Board, as defined by the NASDAQ Capital Market (“Nasdaq”), director independence standards, as well as applicable SEC rules, as currently in effect. The Audit Committee Chair is Howard Slayen. The Audit Committee held four meetings during fiscal year 2022. The Compensation Committee of the Board currently consists of directors Danesh, Oliphant and Slayen, each of whom is an independent member of the Board, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect. The Compensation Committee Chair is Laura Oliphant. The Compensation Committee held three meetings during fiscal year 2022. The Corporate Governance and Nominating Committee of the Board currently consists of directors Oliphant, Rosati and Scott, each of whom is an independent member of the Board, as defined by the Nasdaq director independence standards, as well as applicable SEC rules, as currently in effect. The Corporate Governance and Nominating Committee Chair is Mario Rosati. The Corporate Governance and Nominating Committee of the Board held one meeting during the fiscal year ended May 31, 2022.
2023-09-13	Laura Oliphant (1)(2)(3) 60 Director 2019 ... Committee members attending a committee meeting not held in conjunction with a regular board meeting received the following amounts: Audit Committee chair - $2,500; Audit Committee member - $2,000; Compensation Committee chair - $2,500; other compensation committee members - $2,000; Corporate Governance and Nominating Committee chair - $2,500; and other Corporate Governance and Nominating committee members - $2,000. ... On July 14, 2022, outside directors Fariba Danesh, Laura Oliphant, Rhea Posedel, Mario Rosati, Geoffrey Scott and Howard Slayen were each granted an award of 5,000 RSUs which vested on October 18, 2022, and another award of 5,000 RSUs, each of which vested at the end of fiscal year 2023 upon the achievement of certain revenue goals in fiscal year 2023. ... The following table sets forth the compensation paid by the Company during the fiscal year ended May 31, 2023 to the Company’s outside directors: ... Laura Oliphant 2023 62,000 -- 120,000 -- -- 182,000
2024-09-11	Laura Oliphant (1)(2)(3) 61 Director 2019... (1) Member of the Audit Committee (2) Member of the Compensation Committee (3) Member of the Corporate Governance and Nominating Committee... The following table sets forth the compensation paid by the Company during the fiscal year ended May 31, 2024 to the Company’s outside directors: Laura Oliphant 2024 72,750 0 140,000 0 212,750.